On this page
- Leadership changes at Applied Materials Inc /De (2026)
- Leadership changes at Bicycle Therapeutics Plc (2026)
- Leadership changes at Celsius Holdings, Inc. (2026)
- Leadership changes at Coherent Corp. (2026)
- Leadership changes at Electromed, Inc. (2026)
- Leadership changes at Everspin Technologies Inc. (2026)
- Leadership changes at Foxx Development Holdings Inc. (2026)
- Leadership changes at GoPro, Inc. (2026)
- Leadership changes at Highwater Ethanol LLC (2026)
- Leadership changes at Imax Corp (2026)
- Leadership changes at iRhythm Holdings, Inc. (2026)
- Leadership changes at Longevity Health Holdings, Inc. (2026)
- Leadership changes at Mueller Industries Inc (2026)
- Leadership changes at Netgear, Inc. (2026)
- Leadership changes at Tonix Pharmaceuticals Holding Corp. (2026)
Leadership changes at Applied Materials Inc /De (2026)
Applied Materials Inc /De reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-08-27. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Applied Materials Inc /De files it.
Layoffs on record: 1 filing or notice, latest 2025-10-23 (layoff filings and notices).
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 7.49% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-27 | In | Akash Palkhiwala | 8-K, 2026-08-27 |
New leaders reset buying decisions — get the Full Report on Applied Materials Inc /De: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Applied Materials Inc /De, with the record behind each one.
Find candidates like senior executive at Applied Materials Inc /DeOn August 27, 2026, the Board of Directors (the "Board") of Applied Materials, Inc. ("Applied" or the "Company") elected Akash Palkhiwala to the Board and the Board's Audit Committee, effective immediately.
- The restricted stock units are scheduled to vest in full on March 1, 2027, subject to Mr. Palkhiwala's continued service as a director through that date.
- Mr. Palkhiwala will enter into the Company's standard form of directors' indemnification agreement with Applied, pursuant to which the Company agrees to indemnify its directors to the fullest extent permitted by applicable law and subject to certain conditions to advance expenses in connection with proceedings as described in the indemnification agreement.
Leadership changes at Bicycle Therapeutics Plc (2026)
Bicycle Therapeutics Plc reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-02-03 to 2026-08-20. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Bicycle Therapeutics Plc files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 6.72% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G, by LONG FOCUS CAPITAL MANAGEMENT, LLC | 6.6% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 6.75% of the class | 5%+ stakes | Source |
| May 4, 2026 | Stake report, Schedule 13G/A, by Raymond Debbane | 3.1% of the class | 5%+ stakes | Source |
| March 4, 2026 | Stake report, Schedule 13G/A, by Westfield Capital Management Company, L.P. | — | 5%+ stakes | Source |
| March 3, 2026 | Stake report, Schedule 13G, by Raymond Debbane | 6.3% of the class | 5%+ stakes | Source |
| March 3, 2026 | Stake report, Schedule 13G/A, by Westfield Capital Management Company, L.P. | — | 5%+ stakes | Source |
| March 3, 2026 | Stake report, Schedule 13G/A, by Westfield Capital Management Company, L.P. | — | 5%+ stakes | Source |
| February 18, 2026 | Stake report, Schedule 13G, by Armistice Capital, LLC | 6.48% of the class | 5%+ stakes | Source |
| February 11, 2026 | Stake report, Schedule 13G/A, by Westfield Capital Management Company, L.P. | 6.04% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 4.99% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by Deep Track Capital, LP | 2.42% of the class | 5%+ stakes | Source |
The newest 12 of 13 records.
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-20 | Out | Charles Swanton | Director | 8-K, 2026-08-20 | |
| 2026-03-17 | Reported | not named in the filing | 8-K, 2026-03-17 | ||
| 2026-02-03 | In | Travis Thompson | Chief Financial Officer | 2026-01-29 | 8-K, 2026-02-03 |
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- Charles Swanton, Director (filed 2026-08-20):
Dr. Swanton's resignation was for personal reasons and not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Charles Swanton, departure reported (filed 2026-08-20). No successor is named in these filings.
- Chief Financial Officer: Travis Thompson, appointed, effective 2026-01-29 (filed 2026-02-03).
New leaders reset buying decisions — get the Full Report on Bicycle Therapeutics Plc: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Bicycle Therapeutics Plc, with the record behind each one.
Find candidates like Director at Bicycle Therapeutics PlcOn August 18, 2026, Charles Swanton resigned as a Class II director of the Board of Directors (the "Board") of Bicycle Therapeutics plc (the "Company"), as a member of the Board's committees and as a member of the Company's Clinical Advisory Board, effective immediately.
Dr. Perry will succeed Alistair Milnes, who will serve as the Company's Chief Corporate Development Officer, effective as of the Transition Date.
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers On March 11, 2026, the Company's Board of Directors appointed Jennifer Perry, Pharm.D. as Chief Operating Officer, effective as of March 17, 2026 (the "Transition Date").
- Prior to her appointment as Chief Operating Officer, Dr. Perry, age 52, served as the Company's Chief Strategy Officer and Head of Commercial, a role she held since July 2024.
- Dr. Perry previously served as the Company's Senior Vice President, Commercial, from April 2023 to July 2024, and as the Company's Vice President, Global Scientific Engagement and Medical Affairs from August 2022 to April 2023.
- Dr. Perry has over 20 years of experience in the biotech and pharmaceutical industries, with 15 years in oncology.
- Prior to joining the Company, from August 2020 to August 2022, Dr. Perry served as Vice President, Hematology Oncology Sales at TG Therapeutics, Inc. and previously served as Vice President, US Oncology Sales at GSK/Tesaro from July 2019 to August 2020.
- Dr. Perry attended Loyola University Chicago for her undergraduate education before earning her Pharm.D. from the University of Illinois Chicago.
On January 29, 2026, the Board of Directors (the " Board ") of Bicycle Therapeutics plc (the " Company ") appointed Travis Thompson as Chief Financial Officer, effective as of January 29, 2026 (the " Transition Date ").
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
- Mr. Thompson will succeed Alethia Young, who has transitioned from her role as Chief Financial Officer and all other roles she held with the Company and Bicycle Therapeutics Inc. ("BTI"), effective as of the Transition Date.
- As of the Transition Date, Ms. Young will no longer be an officer, executive, director or agent of either the Company or BTI.
- Following the Transition Date, Ms. Young will remain with the Company in an interim capacity for three months, and thereafter will continue as an advisor to the Company pursuant to the terms of her Separation Agreement (as defined below) and Consulting Agreement (as defined below), each as described below.
- Appointment of Travis Thompson as Chief Financial Officer Prior to his appointment as Chief Financial Officer, Mr. Thompson, age 46, served as the Company's Senior Vice President and Chief Accounting Officer, roles he held since June 2023.
- Mr. Thompson joined the Company in 2018 prior to its initial public offering and has been responsible for scaling the accounting and finance team, processes and systems.
Leadership changes at Celsius Holdings, Inc. (2026)
Celsius Holdings, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-02-10 to 2026-08-10. They name 2 people. Every row below is cited to the filing it comes from, and this page adds each new change as Celsius Holdings, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G/A, by AllianceBernstein L.P. | 3.3% of the class | 5%+ stakes | Source |
| May 18, 2026 | Stake report, Schedule 13G/A, by AllianceBernstein L.P. | 7.7% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Deborah DeSantis | 7.6% of the class | 5%+ stakes | Source |
| January 30, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | 7.01% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by AllianceBernstein L.P. | 6.2% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-10 | Out | Eric Hanson | Chief Operating Officer | 2026-08-10 | 8-K, 2026-08-10 |
| 2026-02-10 | Role change | Tony Guilfoyle | Chief Commercial Officer | 8-K, 2026-02-10 |
Celsius Holdings, Inc.'s filings state no reason for the departures below. Where a filing gives none, it says so here; nothing is inferred.
- Eric Hanson, Chief Operating Officer (filed 2026-08-10): the filing states no reason.
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Operating Officer: Eric Hanson, departure reported, effective 2026-08-10 (filed 2026-08-10). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Celsius Holdings, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Operating Officer at Celsius Holdings, Inc., with the record behind each one.
Find candidates like Chief Operating Officer at Celsius Holdings, Inc.Effective August 10, 2026, Mr. Eric Hanson, President and Chief Operating Officer, departed from Celsius Holdings, Inc. (the "Company").
- Mr. Hanson is eligible to receive severance benefits under the Company's Executive Severance Pay Plan in connection with his departure from the Company, subject to certain conditions of the plan.
Change in Executive Officer Status On February 10, 2026, the Board named Mr. Tony Guilfoyle to the position of Chief Customer Officer, and on such date, Mr. Guilfoyle ceased his position as Chief Commercial Officer.
- Departure of Directors On February 10, 2026, Mr. Israel Kontorvsky and Mr. Michael Del Pozzo resigned from the Board of Directors (the "Board") of Celsius Holdings, Inc., a Nevada corporation (the "Company"), with immediate effect.
- Both Messrs. Kontorovsky and Del Pozzo had been appointed to the Board in accordance with the previously reported Board designation rights of PepsiCo, Inc. ("PepsiCo").
- Appointment of Directors On February 10, 2026, the Board appointed Ms. Chrysso (Christy) Jacoby, 55, and Mr. John Short, 53, as directors to fill the vacancies on the Board created by the departures of Messrs. Kontorovsky and Del Pozzo.
- The Board additionally appointed Ms. Jacoby to serve on the Board's Audit and Enterprise Risk Committee and appointed Mr. Short to serve on the Board's Governance and Nominating Committee.
- Ms. Jacoby's and Mr. Short's terms on the Board commenced on February 10, 2026 and expire at the Company's 2026 annual meeting of stockholders.
- Ms. Jacoby currently serves as Senior Vice President and Chief Financial Officer for PepsiCo North America Operations, where she oversees the financial strategy and performance of PepsiCo's approximately $40 billion foods and beverages business, including Frito Lay, Quaker North America and Pepsi Beverages.
Leadership changes at Coherent Corp. (2026)
Coherent Corp. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-04-28. It names 1 person, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Coherent Corp. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 5, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 4.2% of the class | 5%+ stakes | Source |
| July 8, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 5.6% of the class | 5%+ stakes | Source |
| May 6, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 12.1% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 7.45% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.05% of the class | 5%+ stakes | Source |
| April 24, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 6.6% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 11, 2026 | Stake report, Schedule 13D/A, by BCPE Watson (DE) BML, LP | — | 5%+ stakes | Source |
| February 5, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 15% of the class | 5%+ stakes | Source |
| December 12, 2025 | Stake report, Schedule 13D/A, by BCPE Watson (DE) BML, LP | 5.2% of the class | 5%+ stakes | Source |
| December 4, 2025 | Stake report, Schedule 13D/A, by BCPE Watson (DE) BML, LP | 7.9% of the class | 5%+ stakes | Source |
| November 24, 2025 | Stake report, Schedule 13D/A, by BCPE Watson (DE) BML, LP | 7.9% of the class | 5%+ stakes | Source |
The newest 12 of 16 records.
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-04-28 | Out | Giovanni Barbarossa | Chief Strategy Officer | 8-K, 2026-04-28 | |
| 2026-04-28 | In | Giovanni Barbarossa | Chief Executive Officer | 8-K, 2026-04-28 |
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- Giovanni Barbarossa, Chief Strategy Officer (filed 2026-04-28):
In connection with this transition, Dr. Barbarossa will serve as a Special Advisor to the Chief Executive Officer, effective as of the Transition Date and through the date of his retirement, which will be determined at a later time.
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Giovanni Barbarossa, appointed (filed 2026-04-28).
- Chief Strategy Officer: Giovanni Barbarossa, departure reported (filed 2026-04-28). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Coherent Corp.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Strategy Officer at Coherent Corp., with the record behind each one.
Find candidates like Chief Strategy Officer at Coherent Corp.On April 27, 2026 (the "Transition Date"), Giovanni Barbarossa notified Coherent Corp. (the "Company") of his intention to transition from his role as the Company's Chief Strategy Officer, effective as of the Transition Date, and retire in September 2026.
In connection with this transition, Dr. Barbarossa will serve as a Special Advisor to the Chief Executive Officer, effective as of the Transition Date and through the date of his retirement, which will be determined at a later time.
Leadership changes at Electromed, Inc. (2026)
Electromed, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-08-25. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Electromed, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| July 29, 2025 | Stake report, Schedule 13G, by The Vanguard Group | 5.19% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-25 | Out | James L. Cunniff | President and Chief Executive Officer | 8-K, 2026-08-25 |
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- James L. Cunniff, President and Chief Executive Officer (filed 2026-08-25):
Mr. Cunniff is also expected to resign from the Board upon his retirement.
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- President and Chief Executive Officer: James L. Cunniff, departure reported (filed 2026-08-25). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Electromed, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the President and Chief Executive Officer at Electromed, Inc., with the record behind each one.
Find candidates like President and Chief Executive Officer at Electromed, Inc.On August 25, 2026, James L. Cunniff, President and Chief Executive Officer of the Company, notified the Company of his intention to retire from the Company effective on or about April 2, 2027.
- The Board of Directors of the Company (the "Board") has engaged an executive search firm and is commencing a comprehensive search to identify the Company's next Chief Executive Officer.
Leadership changes at Everspin Technologies Inc. (2026)
Everspin Technologies Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-07-17. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Everspin Technologies Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 10, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 4% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by AWM Investment Company, Inc. | 3.1% of the class | 5%+ stakes | Source |
| August 13, 2026 | Stake report, Schedule 13G/A, by Barclays PLC | 1.89% of the class | 5%+ stakes | Source |
| August 7, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 5.1% of the class | 5%+ stakes | Source |
| July 28, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 6.6% of the class | 5%+ stakes | Source |
| July 27, 2026 | Stake report, Schedule 13G/A, by Sigma Partners 8, L.P. | — | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Lynrock Lake LP | 4.2% of the class | 5%+ stakes | Source |
| May 12, 2026 | Stake report, Schedule 13G/A, by Barclays PLC | 5.02% of the class | 5%+ stakes | Source |
| May 4, 2026 | Stake report, Schedule 13G/A, by AWM Investment Company, Inc. | 8.9% of the class | 5%+ stakes | Source |
| November 12, 2025 | Stake report, Schedule 13G/A, by Barclays PLC | 6.82% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by Lynrock Lake LP | 8.2% of the class | 5%+ stakes | Source |
| July 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 2.3% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-07-17 | Out | Lawrence G. Finch | Director | 2026-08-04 | 8-K, 2026-07-17 |
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- Lawrence G. Finch, Director (filed 2026-07-17):
Mr. Finch's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Lawrence G. Finch, departure reported, effective 2026-08-04 (filed 2026-07-17). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Everspin Technologies Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Everspin Technologies Inc., with the record behind each one.
Find candidates like Director at Everspin Technologies Inc.On July 14, 2026, Lawrence G. Finch notified Everspin Technologies, Inc. (the "Company") of his resignation from the Company's board of directors (the "Board"), including as a member of the Board's audit committee, effective August 4, 2026.
- The Company thanks Mr. Finch for his dedication and years of service to the Company.
Leadership changes at Foxx Development Holdings Inc. (2026)
Foxx Development Holdings Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-01-21 to 2026-08-18. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Foxx Development Holdings Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| May 14, 2026 | Stake report, Schedule 13G, by Clear Street LLC | 10.5% of the class | 5%+ stakes | Source |
| May 8, 2026 | Stake report, Schedule 13D, by BayRoad Holdings Limited | 33.43% of the class | 5%+ stakes | Source |
| May 8, 2026 | Stake report, Schedule 13D, by Grazyna Plawinski Limited | 28.34% of the class | 5%+ stakes | Source |
| May 5, 2026 | Stake report, Schedule 13D/A, by Joy Yi Hua | 28.98% of the class | 5%+ stakes | Source |
| May 5, 2026 | Stake report, Schedule 13D/A, by New Bay Capital Limited | 31.49% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Highbridge Capital Management, LLC | 2.7% of the class | 5%+ stakes | Source |
| November 26, 2025 | Stake report, Schedule 13G, by Alta Partners LLC | 9.8% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-18 | Out | James Liao | Chief Technology Officer | 2026-08-14 | 8-K, 2026-08-18 |
| 2026-01-21 | In | Michelle Jie Shen | Director | 8-K, 2026-01-21 |
Foxx Development Holdings Inc.'s filings state no reason for the departures below. Where a filing gives none, it says so here; nothing is inferred.
- James Liao, Chief Technology Officer (filed 2026-08-18): the filing states no reason.
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Technology Officer: James Liao, departure reported, effective 2026-08-14 (filed 2026-08-18). No successor is named in these filings.
- Director: Michelle Jie Shen, appointed (filed 2026-01-21).
New leaders reset buying decisions — get the Full Report on Foxx Development Holdings Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Technology Officer at Foxx Development Holdings Inc., with the record behind each one.
Find candidates like Chief Technology Officer at Foxx Development Holdings Inc.Effective as of August 14, 2026, Mr. James Liao resigned from his position as Chief Technology Officer of Foxx Development Holdings Inc. (the "Company").
- Mr. Liao also resigned from his position as Chief Technology Officer of Foxx Development Inc., the Company's operating subsidiary.
As previously announced in a current report on Form 8-K on December 29, 2025, on December 22, 2025, Michelle Jie Shen was elected as the director of Foxx Development Holdings Inc. In connection with Ms. Shen's appointment, the Company entered into an offer letter with Ms. Shen on January 20, 2026 (the "Offer Letter") pursuant to which, Ms. Shen is entitled to the receive an annual director fee of $60,000, subject to the review and determination by the Board.
- In addition, the Company also entered into an indemnification agreement (the "Indemnification Agreement") with Ms. Shen, which shall apply retroactively commencing on December 22, 2025.
Leadership changes at GoPro, Inc. (2026)
GoPro, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-02-19 to 2026-08-18. They name 2 people. Every row below is cited to the filing it comes from, and this page adds each new change as GoPro, Inc. files it.
Layoffs on record: about 145 jobs, latest 2026-04-07 (layoff filings and notices).
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 9, 2026 | Stake report, Schedule 13D, by Woodman Nicholas | 20.3% of the class | 5%+ stakes | Source |
| August 20, 2026 | Stake report, Schedule 13G, by Fischbach Mark Edward | 8.5% of the class | 5%+ stakes | Source |
| July 28, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 6.4% of the class | 5%+ stakes | Source |
| April 21, 2026 | Stake report, Schedule 13G/A, by Brumder William George | 1.3% of the class | 5%+ stakes | Source |
| March 13, 2026 | Form D, private offering | $25M sold | Form D page | Source |
| January 30, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | 4.9% of the class | 5%+ stakes | Source |
| October 30, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 5.05% of the class | 5%+ stakes | Source |
| August 28, 2025 | Stake report, Schedule 13G/A, by Brumder William George | 9.7% of the class | 5%+ stakes | Source |
| August 21, 2025 | Stake report, Schedule 13G, by Brumder William George | 8.5% of the class | 5%+ stakes | Source |
| July 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 2.1% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-18 | In | Brian Tratt | Chief Financial Officer | 2026-08-14 | 8-K, 2026-08-18 |
| 2026-02-19 | In | Brian McGee | Chief Financial Officer and Chief Operating Officer | 8-K, 2026-02-19 | |
| 2026-02-19 | In | Brian Tratt | Chief Financial Officer | 8-K, 2026-02-19 |
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Brian Tratt, appointed, effective 2026-08-14 (filed 2026-08-18).
- Chief Financial Officer and Chief Operating Officer: Brian McGee, appointed (filed 2026-02-19).
New leaders reset buying decisions — get the Full Report on GoPro, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at GoPro, Inc., with the record behind each one.
Find candidates like Chief Financial Officer at GoPro, Inc.Effective August 14, 2026, Brian Tratt was promoted to Senior Vice President, Chief Financial Officer of GoPro, Inc. (the "Company").
- Mr. Tratt previously served as Vice President, Chief Financial Officer.
- In connection with Mr. Tratt's promotion, his annual base salary was increased from $385,000 to $420,000, and his annual discretionary bonus target was increased from 60% to 75%.
On February 19, 2026, the Company announced that the Board of Directors (the "Board") of the Company has appointed Brian McGee, age 66, the Company's current EVP, Chief Financial Officer and Chief Operating Officer, to assume the role of President & Chief Operating Officer effective at the close of business on the Effective Date.
On February 19, 2026, the Company announced that the Board of the Company has appointed Brian Tratt, age 42, the Company's current Vice President, Finance, to serve as the Company's Chief Financial Officer, effective at the close of business on the Effective Date, filling the position vacated by Mr. McGee, who transitions to President & Chief Operating Officer of the Company at the close of business on the Effective Date.
- On February 19, 2026, GoPro, Inc. (the "Company") announced leadership promotions to be effective as of March 17, 2026 (the "Effective Date").
- Brian McGee will continue to hold the Chief Operating Officer role.
- When Mr. McGee transitions to his role as President & Chief Operating Officer at the close of business on the Effective Date, Mr. McGee will vacate his position as Chief Financial Officer of the Company.
- Mr. McGee has served as the Company's Chief Operating Officer since February 2020, and the Company's Executive Vice President, Chief Financial Officer since February 2018 and Senior Vice President, Chief Financial Officer since March 2016.
- Mr. McGee served as the Company's Vice President of Finance since September 2015, which included responsibility for financial planning, tax, treasury and risk management.
- From May 2011 to September 2015, Mr. McGee served in various positions at Qualcomm, including the Vice President of Business Operations.
- Mr. McGee holds a B.S. in Finance from California Polytechnic State University (1983) and a Certificate in Management Accounting (1989).
- The Company has not made any changes to Mr. McGee's compensation arrangement in connection with his appointment into this new position.
- Mr. Tratt has served as the Vice President, Finance since August 2024.
Leadership changes at Highwater Ethanol LLC (2026)
Highwater Ethanol LLC reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-07-29 to 2026-08-20. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Highwater Ethanol LLC files it.
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-20 | In | Michael D. Stein | 8-K, 2026-08-20 | ||
| 2026-07-29 | Out | William Garth | 8-K, 2026-07-29 |
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- William Garth (filed 2026-07-29):
Mr. Garth did not resign his position because of a disagreement with the Company.
New leaders reset buying decisions — get the Full Report on Highwater Ethanol LLC: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Highwater Ethanol LLC, with the record behind each one.
Find candidates like senior executive at Highwater Ethanol LLCOn August 19, 2026, the board of governors of Highwater Ethanol, LLC (the "Board") appointed Michael D. Stein to fill a vacancy on the Board.
- Mr. Stein will serve for the unexpired term of his predecessor or until 2029.
- Mr. Stein has been appointed to serve on the risk management, audit and fixed assets committees.
On July 27, 2026, William Garth resigned from his position on the Board of Governors of Highwater Ethanol, LLC (the "Company") effective the same date.
Leadership changes at Imax Corp (2026)
Imax Corp reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-04-17. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Imax Corp files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G/A, by NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 5.4% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Orbis Investment Management Limited | 9.3% of the class | 5%+ stakes | Source |
| August 6, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 4.2% of the class | 5%+ stakes | Source |
| July 29, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.2% of the class | 5%+ stakes | Source |
| June 3, 2026 | Stake report, Schedule 13G/A, by Westfield Capital Management Company, L.P. | 4.99% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 6.8% of the class | 5%+ stakes | Source |
| May 7, 2026 | Stake report, Schedule 13G, by GIC Private Limited | 5.23% of the class | 5%+ stakes | Source |
| May 5, 2026 | Stake report, Schedule 13G, by Westfield Capital Management Company, L.P. | 5.01% of the class | 5%+ stakes | Source |
| March 17, 2026 | Stake report, Schedule 13D/A, by Kevin Douglas | 15.5% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G, by NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 7.9% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Orbis Investment Management Limited | 9.5% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Macquarie Group Limited | — | 5%+ stakes | Source |
The newest 12 of 18 records.
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-04-17 | In | Robert D. Lister | Chief Legal Officer | 8-K, 2026-04-17 |
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Legal Officer: Robert D. Lister, appointed (filed 2026-04-17).
New leaders reset buying decisions — get the Full Report on Imax Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Legal Officer at Imax Corp, with the record behind each one.
Find candidates like Chief Legal Officer at Imax CorpOn April 16, 2026, the Company's board of directors (the "Board") appointed Robert D. Lister, the Company's Chief Legal Officer and Senior Executive Vice President, to serve as the Company's interim principal executive officer ("PEO") in addition to his current duties until May 1, 2026, following which Mr. Gelfond will resume the role of PEO.
- As previously announced on March 30, 2026, Richard Gelfond, the Chief Executive Officer of IMAX Corporation (the "Company"), is on a temporary medical leave of absence.
- Mr. Lister will not receive any additional compensation in connection with his temporary interim appointment.
Leadership changes at iRhythm Holdings, Inc. (2026)
iRhythm Holdings, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-03-12 to 2026-08-13. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as iRhythm Holdings, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 12, 2026 | Stake report, Schedule 13G/A, by Artisan Partners Asset Management Inc. | 6.7% of the class | 5%+ stakes | Source |
| October 13, 2026 | Stake report, Schedule 13G/A, by Millennium Management LLC | 1.1% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by RTW Investments, LP | 6.6% of the class | 5%+ stakes | Source |
| August 13, 2026 | Stake report, Schedule 13G, by Artisan Partners Asset Management Inc. | 5.1% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G, by RTW Investments, LP | 5.2% of the class | 5%+ stakes | Source |
| May 8, 2026 | Stake report, Schedule 13G/A, by SANDS CAPITAL MANAGEMENT, LLC | — | 5%+ stakes | Source |
| April 28, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.64% of the class | 5%+ stakes | Source |
| April 27, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.23% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| March 23, 2026 | Stake report, Schedule 13G, by Millennium Management LLC | 5.1% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by SANDS CAPITAL MANAGEMENT, LLC | 5.3% of the class | 5%+ stakes | Source |
| February 3, 2026 | Stake report, Schedule 13G/A, by Artisan Partners Asset Management Inc. | 4.7% of the class | 5%+ stakes | Source |
The newest 12 of 14 records.
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-13 | Out | Brian Yoor | Director | 2026-08-12 | 8-K, 2026-08-13 |
| 2026-03-12 | In | Jason Patten | Director | 2026-03-12 | 8-K, 2026-03-12 |
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- Brian Yoor, Director (filed 2026-08-13):
Mr. Yoor's resignation from the Board was for personal reasons and not based on any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Brian Yoor, departure reported, effective 2026-08-12 (filed 2026-08-13). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on iRhythm Holdings, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at iRhythm Holdings, Inc., with the record behind each one.
Find candidates like Director at iRhythm Holdings, Inc.(b) On August 11, 2026, Brian Yoor notified iRhythm Holdings, Inc. (the "Company") of his decision to resign from his position as a member of the Board of Directors of the Company (the "Board") and as a member and chair of the Audit Committee of the Board (the "Audit Committee"), effective August 12, 2026.
- The Board has appointed Karen McGinnis, a member of the Board and Audit Committee, as chair of the Audit Committee, effective August 12, 2026.
Effective as of March 12, 2026, the Board of Directors (the "Board") of iRhythm Holdings, Inc., a Delaware corporation (the "Company") appointed Jason Patten as a director of the Board and member of the Audit Committee of the Board (the "Audit Committee").
- Mr. Patten shall hold office for a term expiring at the 2026 Annual Meeting of the Company's stockholders.
- Consistent with the Company's compensation policy for non-employee directors (the "Director Compensation Policy"), upon appointment, Mr. Patten was granted an initial retainer grant of restricted stock units with a grant date value of $300,000 vesting annually over the three years following March 12, 2026.
- Mr. Patten will also receive the customary annual compensation paid to non-employee directors in the form of a cash retainer, paid quarterly in arrears, for his service on the Board and the Audit Committee in an amount consistent with the Director Compensation Policy (currently $55,000 per year for service on the Board and $10,000 per year for service on the Audit Committee).
- The initial retainer grant will be issued under the Company's 2016 Equity Incentive Plan and will accelerate in full upon a change of control, provided that Mr. Patten remains in service through such change in control.
- Prior to being appointed to the Board, Mr. Patten served as an advisor to the Company's President and Chief Executive Officer.
- In connection with that role, Mr. Patten received a one time payment of $86,771 in cash for services rendered.
Leadership changes at Longevity Health Holdings, Inc. (2026)
Longevity Health Holdings, Inc. reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-03-17 to 2026-08-14. They name 3 people, with 2 appointments and 2 departures. Every row below is cited to the filing it comes from, and this page adds each new change as Longevity Health Holdings, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 8, 2026 | Stake report, Schedule 13D, by Ajjarapu J. Ram | 27.9% of the class | 5%+ stakes | Source |
| March 30, 2026 | Form D, private offering | $200K sold | Form D page | Source |
| January 29, 2025 | Form D, private offering | $975K sold | Form D page | Source |
| January 14, 2025 | Form D, private offering | $1.85M sold | Form D page | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-14 | Out | Scott Frisch | 2026-08-11 | 8-K, 2026-08-14 | |
| 2026-06-04 | Out | Kathryn Gregory | 2026-06-01 | 8-K, 2026-06-04 | |
| 2026-03-17 | In | Janakiram Ajjarapu | Chief Executive Officer | 8-K, 2026-03-17 | |
| 2026-03-17 | In | Janakiram Ajjarapu | 8-K, 2026-03-17 |
For each named departures below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- Scott Frisch (filed 2026-08-14):
Mr. Frisch's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- Kathryn Gregory (filed 2026-06-04):
Ms. Gregory's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Janakiram Ajjarapu, appointed (filed 2026-03-17).
New leaders reset buying decisions — get the Full Report on Longevity Health Holdings, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportWatch Longevity Health Holdings, Inc. (free up to 3)
Find people with the same kind of experience as the Chief Executive Officer at Longevity Health Holdings, Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Longevity Health Holdings, Inc.On August 11, 2026, Scott Frisch notified Longevity Health Holdings, Inc. (the "Company") of his resignation from the Board of Directors of the Company, effective as of the close of business on August 11, 2026.
On June 1, 2026, Kathryn Gregory notified Longevity Health Holdings, Inc. (the "Company") of her resignation from the Board of Directors of the Company, effective as of the close of business on June 1, 2026.
Effective as of the Closing Date, the Board appointed Janakiram Ajjarapu as the Chief Executive Officer of the Company, a Class III director of the Company and the Chairman of the Board.
Mr. Ajjarapu was appointed to Class III of the Board to fill the vacancy created by Mr. Shukla stepping down from the Board.
- Resignation of Rajiv S. Shukla Effective as of the Closing Date, Rajiv S. Shukla stepped down from his positions as the Chief Executive Officer of the Company, a Class III director of the Company and the Chairman of the Board.
- The cessation of Mr. Shukla's service with the Company was the result of a mutual agreement between Mr. Shukla and the Company related to the Company's strategic objectives and not due to any disagreement between the Company and Mr. Shukla regarding the Company's operations, policies, or practices.
- On March 13, 2026, the Company and Mr. Shukla entered into a Separation and Release of Claims Agreement (the "Separation Agreement").
- Any vested or unvested stock options or other equity awards held by Mr. Shukla, including those awarded under the Company's 2023 Long-Term Incentive Plan, and any rights to future equity awards granted under Mr. Shukla's Amended and Restated Executive Employment Agreement, dated July 30, 2024, shall be forfeited upon the cessation of Mr. Shukla's employment with the Company.
- Mr. Shukla has agreed that, during the Severance Period, he will provide occasional assistance to the Company as reasonably requested, including making periodic introductions to his financial and commercial contacts in his sole and absolute discretion and leveraging his expertise and institutional knowledge for the benefit of the Company.
Leadership changes at Mueller Industries Inc (2026)
Mueller Industries Inc reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-08-10. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Mueller Industries Inc files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.24% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| July 29, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 9.52% of the class | 5%+ stakes | Source |
| July 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 8.8% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-10 | Out | Gary S. Gladstein | 2026-12-31 | 8-K, 2026-08-10 |
Mueller Industries Inc's filings state no reason for the departures below. Where a filing gives none, it says so here; nothing is inferred.
- Gary S. Gladstein (filed 2026-08-10): the filing states no reason.
New leaders reset buying decisions — get the Full Report on Mueller Industries Inc: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Mueller Industries Inc, with the record behind each one.
Find candidates like senior executive at Mueller Industries IncOn August 6, 2026, Mr. Gary S. Gladstein notified the Board of Directors (the "Board") of Mueller Industries, Inc. (the "Company") that he will retire from the Board effective December 31, 2026.
- Mr. Gladstein previously served as a member of the Board from 1990 to 1994 and then rejoined the Board in 2000.
- He later held the positions of Chairman of the Board from 2013 to 2015 and Lead Independent Director from 2016 to 2018.
Leadership changes at Netgear, Inc. (2026)
Netgear, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-16 to 2026-08-06. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Netgear, Inc. files it.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 30, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.06% of the class | 5%+ stakes | Source |
| October 27, 2026 | Stake report, Schedule 13G, by BlackRock Portfolio Management LLC | 5.6% of the class | 5%+ stakes | Source |
| August 13, 2026 | Stake report, Schedule 13G/A, by BRANDES INVESTMENT PARTNERS, LP | 6.6% of the class | 5%+ stakes | Source |
| July 31, 2026 | Stake report, Schedule 13G/A, by Vanguard Capital Management | 4.94% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.05% of the class | 5%+ stakes | Source |
| April 9, 2026 | Stake report, Schedule 13G/A, by Dimensional Fund Advisors LP | 4% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| March 3, 2026 | Stake report, Schedule 13G/A, by BRANDES INVESTMENT PARTNERS, LP | 10.7% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G, by Windward Management LP | 5.1% of the class | 5%+ stakes | Source |
| February 11, 2026 | Stake report, Schedule 13G/A, by Pertento Partners LLP | 3.4% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G/A, by BRANDES INVESTMENT PARTNERS, LP | 5.8% of the class | 5%+ stakes | Source |
| August 12, 2025 | Stake report, Schedule 13G/A, by BRANDES INVESTMENT PARTNERS, LP | 5.5% of the class | 5%+ stakes | Source |
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-06 | In | Douglas Murray | Director | 8-K, 2026-08-06 | |
| 2026-04-16 | Out | Bradley L. Maiorino | Director | 8-K, 2026-04-16 |
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- Bradley L. Maiorino, Director (filed 2026-04-16):
Mr. Maiorino's decision was made solely due to increased demands from his new full-time executive role and is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Douglas Murray, appointed (filed 2026-08-06).
New leaders reset buying decisions — get the Full Report on Netgear, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Netgear, Inc., with the record behind each one.
Find candidates like Director at Netgear, Inc.(d) On August 3, 2026, the Board of Directors (the "Board") of NETGEAR elected Douglas Murray to serve as a member of the Board, effective immediately.
- The Board has not yet determined Mr. Murray's committee assignment.
- NETGEAR and Mr. Murray also entered into NETGEAR's standard Indemnification Agreement for directors.
(b) On April 12, 2026, Bradley L. Maiorino, a member of the Board of Directors (the "Board") of NETGEAR, Inc. (the "Company"), informed the Company that he will not stand for re-election at the upcoming 2026 Annual Meeting of Stockholders (Annual Meeting).
- Mr. Maiorino will continue to serve as a director, Chair of the Company's Cybersecurity Committee (the "Cybersecurity Committee"), and member of the Company's Audit Committee (the "Audit Committee") until the Annual Meeting.
- The Board will appoint Directors to replace his Committee seats and post them on the Company's Committee Governance website before the date of the Annual Meeting.
- The Company thanks Mr. Maiorino for his 8 years of service and dedication to the Company and its stockholders.
Leadership changes at Tonix Pharmaceuticals Holding Corp. (2026)
Tonix Pharmaceuticals Holding Corp. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-07-21 to 2026-08-18. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Tonix Pharmaceuticals Holding Corp. files it.
Layoffs on record: about 23 jobs, latest 2024-05-22 (layoff filings and notices).
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 13, 2026 | Stake report, Schedule 13G/A, by AQR Capital Management, LLC | 3.91% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Sirenia Capital Management LP | 4.9% of the class | 5%+ stakes | Source |
| August 13, 2026 | Stake report, Schedule 13G, by AQR Capital Management, LLC | 5.54% of the class | 5%+ stakes | Source |
| June 15, 2026 | Stake report, Schedule 13G, by Millennium Management LLC | 5.6% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G, by Sirenia Capital Management LP | 8.8% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Point72 Asset Management, L.P. | 6.9% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| January 30, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | 5.02% of the class | 5%+ stakes | Source |
| January 21, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 6.7% of the class | 5%+ stakes | Source |
| December 31, 2025 | Stake report, Schedule 13G, by Point72 Asset Management, L.P. | 9.2% of the class | 5%+ stakes | Source |
| October 31, 2025 | Stake report, Schedule 13G, by The Vanguard Group | 6.35% of the class | 5%+ stakes | Source |
| October 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 7.8% of the class | 5%+ stakes | Source |
The newest 12 of 13 records.
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-18 | In | Seth Lederman | Chief Medical Officer | 8-K, 2026-08-18 | |
| 2026-07-21 | Out | Gregory M. Sullivan | Chief Medical Officer | 2026-08-20 | 8-K, 2026-07-21 |
Tonix Pharmaceuticals Holding Corp.'s filings state no reason for the departures below. Where a filing gives none, it says so here; nothing is inferred.
- Gregory M. Sullivan, Chief Medical Officer (filed 2026-07-21): the filing states no reason.
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Medical Officer: Gregory M. Sullivan, departure reported, effective 2026-08-20 (filed 2026-07-21). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Tonix Pharmaceuticals Holding Corp.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Medical Officer at Tonix Pharmaceuticals Holding Corp., with the record behind each one.
Find candidates like Chief Medical Officer at Tonix Pharmaceuticals Holding Corp.Interim Chief Medical Officer On August 18, 2026, the Board of Directors of Tonix Pharmaceuticals Holding Corp. (the "Company") appointed Dr. Seth Lederman, the Company's President and Chief Executive Officer, as the Company's Interim Chief Medical Officer.
- Dr. Lederman, age 69, has been the Company's President, Chief Executive Officer and Chairman of the Board since October 2011, and will continue to serve in these roles.
On July 20, 2026, Dr. Gregory M. Sullivan informed Tonix Pharmaceuticals Holding Corp. (the "Company") that he will retire from his role as Chief Medical Officer of the Company, effective August 20, 2026.
